Area of research
Immunology · Molecular Biology
Research interest
Research interests include Immunotherapy and Immune Responses, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and vaccines and immunoinformatics approaches.
Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML
Polyamines regulate adaptive antitumor immunity by functional specialization of regulatory T cells
Polyamines regulate adaptive antitumor immunity by functional specialization of regulatory T cells.
Atypical MAPKs in cancer.
[Infections and multiple sclerosis].
Thunder-DDA-PASEF enables high-coverage immunopeptidomics and is boosted by MS2Rescore with MS2PIP timsTOF fragmentation prediction model
Thunder-DDA-PASEF enables high-coverage immunopeptidomics and is boosted by MS<sup>2</sup>Rescore with MS<sup>2</sup>PIP timsTOF fragmentation prediction model.
Atypical <scp>MAPK</scp>s in cancer
Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development.
Infektionen und Multiple Sklerose
Editorial: Understanding convergent evasion mechanisms in cancer and chronic infection: implications for immunotherapy
Editorial: Understanding convergent evasion mechanisms in cancer and chronic infection: implications for immunotherapy.
[Immunological foundations of neurological diseases].
Cross-presenting Langerhans cells are required for the early reactivation of resident CD8 <sup>+</sup> memory T cells in the epidermis
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product.
Peptide-Decorated Degradable Polycarbonate Nanogels for Eliciting Antigen-Specific Immune Responses
Cross-presenting Langerhans cells are required for the early reactivation of resident CD8<sup>+</sup> memory T cells in the epidermis.
Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development
Tumor-infiltrating CCR2+ inflammatory monocytes counteract specific immunotherapy
Tumor-infiltrating CCR2<sup>+</sup> inflammatory monocytes counteract specific immunotherapy.
Modulation of cellular transcriptome and proteome composition by azidohomoalanine-implications on click chemistry-based secretome analysis.
Modulation of cellular transcriptome and proteome composition by azidohomoalanine—implications on click chemistry–based secretome analysis
Peptide-Decorated Degradable Polycarbonate Nanogels for Eliciting Antigen-Specific Immune Responses.
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
Solid tumors exploit proton-sensing GPR65 for orchestration of an immunosuppressive tumor microenvironment
Author Correction: Dithranol as novel co-adjuvant for non-invasive dermal vaccination.
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors.
CD27 expression on Treg cells limits immune responses against tumors.
Transient Lymph Node Immune Activation by Hydrolysable Polycarbonate Nanogels